John L. Sullivan, CFA

Director of Research, Managing Director, Life Science Tools and Services

John L. Sullivan is Director of Research at Leerink Swann. He is also an analyst in the life sciences tools and consumables sector. Mr. Sullivan recently ranked #3 in The Wall Street Journal’s 2008 “Best on the Street” analysts’ survey. As a stock picker in 2007, he earned a #2 ranking among the life sciences tools and services analysts ranked by Starmine in Forbes.com and a #3 ranking among the same group for accuracy of his earnings estimates. Previously, Mr. Sullivan was a Vice President, Senior Equity Research Analyst, Life Sciences, at Stephens Inc. where his primary focus was on companies possessing enabling technologies for health care-related products for research and drug discovery. He ranked #2 among biotechnology analysts in the NASDAQ-StarMine industry survey of 2002 earnings estimate accuracy. He previously was a Senior Equity Research Analyst, Healthcare Services and Medical Devices at Tucker Anthony Cleary Gull Inc. where he was named the best of 35 healthcare analysts in earnings forecasting and fourth of 50 healthcare analysts in stock picking in The Wall Street Journal's "Best on the Street" 2000 analysts' survey. Mr. Sullivan, a Chartered Financial Analyst, received his Bachelor of Science degree from Boston University and an MBA from J.L. Kellogg Graduate School of Management at Northwestern University.